Observational Study on the Patient's Ability to Use a Digital Platform in Heart Failure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

6 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-24

Study Completion Date

2025-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Heart Failure has a global prevalence of 1 to 3% in the adult population with an incidence of 1 to 20 cases per 1,000 people. Furthermore, HF is often associated with a number of comorbidities (anaemia, arrhythmias, depression, hyperuricemia, coronary heart disease etc.), which greatly deteriorates the patient's quality of life.

Despite the development of specific drugs, HF has a very high mortality rate, and it is the first cause of unscheduled income. An increase of 50% of these incomes is expected in the next 25 years.

In this context, the use of digital tools/platforms that allow remote monitoring of patients and that facilitate telemedicine have shown potential to improve treatment adherence and facilitate continued therapeutic education, improving clinical results with savings in time and associated costs.

This study focuses on studying the ability of heart failure patients with reduced ejection fraction (EF≤40%) to use a digital platform through an application installed on the patient's smartphone.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Heart Failure Events Reduction With Remote Monitoring and eHealth Support Investigator Initiated Trial

NCT03663907

Heart Failure

COMPLETED NA

Prognostic Impact of Noncardiac Comorbidities in Heart Failure Patients

NCT02946476

Heart Failure, Diastolic Heart Failure, Systolic

COMPLETED

Improvement of a Digital Health Platform for Remote Monitoring of Patients With Heart Failure

NCT05708846

Heart Failure

COMPLETED

Role of Comorbidities in Chronic Heart Failure Study

NCT02922478

Heart Failure Comorbidity Osteoporosis +3 more

COMPLETED

Strategy TO Prevent Decompensated Heart Failure

NCT06641921

Heart Failure Remote Monitoring

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an observational, prospective, single-center study. The protocol and informed consent document have been reviewed and approved by the Ethical Committee and the study will be performed in accordance with the Declaration of Helsinki

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years or older
* Informed Consent is obtained from the patient
* Patients diagnosed with heart failure with reduced ejection fraction (EF≤40%)
* Patients who extensively use a smartphone.

Exclusion Criteria

* Patients who will not be able to commit to carrying out the follow-ups or do not have adequate technological skills.
* Patients with inability to give adequately the informed consent.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No